Organon (OGN) reachead $19.17 at the closing of the latest trading day, reflecting a +0.74% change compared to its last close.
U.S. House candidate Prasanth Reddy has taken large sums of money from the pharmaceutical industry throughout his career. Some of these companies have tried to block legislation aimed at lowering ...
CNW/ - In recognition of World Contraception Day (WCD) on September 26, Organon Canada, a subsidiary of Organon (NYSE: OGN), ...
Organon & Co (OGN) stock saw a decline, ending the day at $19.66 which represents a decrease of $-0.06 or -0.30% from the prior close of $19.72. The stock opened at $19.8 and touched a low of $19.51 ...
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Organon shares have stabilized in recent times, with gradual debt reduction and structural growth allowing for a valuation re ...
GET MORE AI-GENERATED SIGNALS: September 21, 2024, 08:24 am ET, BY Jake B.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...
Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...
Organon & Co (OGN) stock saw a decline, ending the day at $19.97 which represents a decrease of $-0.58 or -2.82% from the prior close of $20.55. The stock opened at $20.51 and touched a low of $19.42 ...
Barclays analyst Balaji Prasad maintained a Buy rating on Organon (OGN – Research Report) today and set a price target of $26.00. The ...
Organon & Co (NYSE:OGN) has agreed to acquire Roivant Sciences Ltd’s (NASDAQ:ROIV) Dermavant Sciences Ltd, which is focused ...
Evercore ISI analyst Umer Raffat maintained a Buy rating on Organon (OGN – Research Report) today. The company’s shares opened ...